Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Accounts Payables (2020 - 2024)

Historic Accounts Payables for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $4.8 million.

  • Burning Rock Biotech's Accounts Payables rose 3401.06% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 3401.06%. This contributed to the annual value of $4.6 million for FY2024, which is 8172.17% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Accounts Payables stood at $4.8 million, which was up 3401.06% from $4.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Accounts Payables high stood at $27.1 million for Q4 2021, and its period low was $579000.0 during Q2 2022.
  • Over the past 5 years, Burning Rock Biotech's median Accounts Payables value was $4.6 million (recorded in 2024), while the average stood at $6.6 million.
  • In the last 5 years, Burning Rock Biotech's Accounts Payables tumbled by 9220.94% in 2022 and then surged by 48514.68% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Accounts Payables (Quarter) stood at $27.1 million in 2021, then tumbled by 72.74% to $7.4 million in 2022, then plummeted by 65.56% to $2.5 million in 2023, then skyrocketed by 81.72% to $4.6 million in 2024, then rose by 4.15% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $4.5 million for Q2 2025, and $5.0 million during Q1 2025.